Qube Research & Technologies Ltd

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in EWTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$50,889,359

+$24,873,194 QoQ

Shares Held

1,252,507

+51.7% QoQ

Ownership

1.15%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#22

of 223 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. EWTX ranks #15 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$50,889,359	1,252,507	+51.7%	Shares	Sole	2026-08-14
2026-03-31	$26,016,165	825,910	+178.8%	Shares	Sole	2026-05-15
2025-12-31	$7,350,401	296,208	-46.7%	Shares	Sole	2026-02-17
2025-09-30	$9,013,664	555,713	+11.2%	Shares	Sole	2025-11-14
2025-06-30	$6,553,911	499,917	+25.7%	Shares	Sole	2025-08-14
2025-03-31	$8,746,606	397,573	+7.6%	Shares	Sole	2025-05-15
2024-12-31	$9,864,101	369,442	+180.1%	Shares	Sole	2025-02-14
2024-09-30	$3,520,197	131,892	+357.2%	Shares	Sole	2024-11-14
2024-06-30	$519,498	28,845	+220.4%	Shares	Sole	2024-08-14
2024-03-31	$164,196	9,002	+344.3%	Shares	Sole	2024-05-14
2023-12-31	$22,164	2,026	-88.8%	Shares	Sole	2024-02-13
2021-12-31	$276,231	18,078	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.